135 related articles for article (PubMed ID: 32768003)
21. Using molecular diagnostic testing to personalize the treatment of patients with gastrointestinal stromal tumors.
Bannon AE; Klug LR; Corless CL; Heinrich MC
Expert Rev Mol Diagn; 2017 May; 17(5):445-457. PubMed ID: 28317407
[TBL] [Abstract][Full Text] [Related]
22. Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.
Parikh AR; He Y; Hong TS; Corcoran RB; Clark JW; Ryan DP; Zou L; Ting DT; Catenacci DV; Chao J; Fakih M; Klempner SJ; Ross JS; Frampton GM; Miller VA; Ali SM; Schrock AB
Oncologist; 2019 Oct; 24(10):1340-1347. PubMed ID: 31040255
[TBL] [Abstract][Full Text] [Related]
23. [ASCO-update 2015 - highlights of the 51. meeting of the american society of clinical oncology/ASCO 2015].
Lorenzen S; Arnold D; Fottner C; Leichsenring J; Moehler M; Seufferlein T; Vogel A; Weber MM; Reinacher-Schick A
Z Gastroenterol; 2016 Feb; 54(2):167-72. PubMed ID: 26854837
[TBL] [Abstract][Full Text] [Related]
24. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines.
Nishida T; Blay JY; Hirota S; Kitagawa Y; Kang YK
Gastric Cancer; 2016 Jan; 19(1):3-14. PubMed ID: 26276366
[TBL] [Abstract][Full Text] [Related]
25. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
[TBL] [Abstract][Full Text] [Related]
26. Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome.
Innocenti F; Ou FS; Qu X; Zemla TJ; Niedzwiecki D; Tam R; Mahajan S; Goldberg RM; Bertagnolli MM; Blanke CD; Sanoff H; Atkins J; Polite B; Venook AP; Lenz HJ; Kabbarah O
J Clin Oncol; 2019 May; 37(14):1217-1227. PubMed ID: 30865548
[TBL] [Abstract][Full Text] [Related]
27. A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers.
Mathur D; Root AR; Bugaj-Gaweda B; Bisulco S; Tan X; Fang W; Kearney JC; Lucas J; Guffroy M; Golas J; Rohde CM; Stevens C; Kamperschroer C; Kelleher K; Lawrence-Henderson RF; Upeslacis E; Yao J; Narula J; LaVallie ER; Fernandez DR; Buetow BS; Rosfjord E; Bloom L; King LE; Tchistiakova L; Nguyen A; Sapra P
Clin Cancer Res; 2020 May; 26(9):2188-2202. PubMed ID: 31996389
[TBL] [Abstract][Full Text] [Related]
28. Gastrointestinal cancer: recent developments in medical oncology.
Chong G; Cunningham D
Eur J Surg Oncol; 2005 Jun; 31(5):453-60. PubMed ID: 15922879
[TBL] [Abstract][Full Text] [Related]
29. Predictive and prognostic factors in the complex treatment of patients with colorectal cancer.
László L
Magy Onkol; 2010 Dec; 54(4):383-94. PubMed ID: 21163770
[TBL] [Abstract][Full Text] [Related]
30. Point-of-care testing in the diagnosis of gastrointestinal cancers: current technology and future directions.
Huddy JR; Ni MZ; Markar SR; Hanna GB
World J Gastroenterol; 2015 Apr; 21(14):4111-20. PubMed ID: 25892860
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer: a retrospective observational study.
Wang X; Wei Q; Gao J; Li J; Li J; Gong J; Li Y; Shen L
Chin J Cancer; 2017 Oct; 36(1):81. PubMed ID: 29037218
[TBL] [Abstract][Full Text] [Related]
32. New concepts of staging in gastrointestinal tumors as a basis of diagnosis and multimodal therapy.
Gretschel S; Moesta KT; Hünerbein M; Lange T; Gebauer B; Stroszczinski C; Bembenek A; Schlag PM
Onkologie; 2004 Feb; 27(1):23-30. PubMed ID: 15007245
[TBL] [Abstract][Full Text] [Related]
33. [New perspectives in diagnosis and therapy of endocrine gastroenteropancreatic (GEP) tumors with somatostatin analogues].
Rubello D; Rufini V; De Carlo E; Martini C; Calcagni ML; Sicolo N; Troncone L; Casara D
Minerva Endocrinol; 2003 Dec; 28(4):259-96. PubMed ID: 14752399
[TBL] [Abstract][Full Text] [Related]
34. [Gastrointestinal oncology].
Stiefelhagen P
Internist (Berl); 2005 Feb; 46(2):216-25. PubMed ID: 15655683
[No Abstract] [Full Text] [Related]
35. Recent advances in diagnosis and treatment for malignancies of the gastrointestinal tract.
Watanabe M; Baba H; Ishioka C; Nishimura Y; Muto M
Digestion; 2012; 85(2):95-8. PubMed ID: 22269286
[TBL] [Abstract][Full Text] [Related]
36. New developments in gastrointestinal stromal tumor.
Trent JC; Benjamin RS
Curr Opin Oncol; 2006 Jul; 18(4):386-95. PubMed ID: 16721136
[TBL] [Abstract][Full Text] [Related]
37. Duodenal gastrointestinal stromal tumor: From clinicopathological features to surgical outcomes.
Marano L; Boccardi V; Marrelli D; Roviello F
Eur J Surg Oncol; 2015 Jul; 41(7):814-22. PubMed ID: 25956211
[TBL] [Abstract][Full Text] [Related]
38. Neuroendocrine tumors of the gastrointestinal tract: recent advances in molecular genetics, diagnosis, and treatment.
Oberg K
Curr Opin Oncol; 2005 Jul; 17(4):386-91. PubMed ID: 15933475
[TBL] [Abstract][Full Text] [Related]
39. The prognostic role of microsatellite instability, codon-specific KRAS, and BRAF mutations in colon cancer.
Lin CC; Lin JK; Lin TC; Chen WS; Yang SH; Wang HS; Lan YT; Jiang JK; Yang MH; Chang SC
J Surg Oncol; 2014 Sep; 110(4):451-7. PubMed ID: 24964758
[TBL] [Abstract][Full Text] [Related]
40. Outlook: Immunotherapy in Gastrointestinal Carcinoma - Innovative Strategies.
Moehler M; Göpfert K; Lenz HJ
Oncol Res Treat; 2018; 41(5):313-315. PubMed ID: 29705792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
